Cart is empty One main goal of anti-cancer therapies is to kill tumor cells without affecting the surrounding normal cells. Therefore, many drugs are designed to target tumor-specific antigens, which are molecules only expressed by cancer cells. However, it has proven difficult to identify such specific antigens in certain cancer types, including acute myeloid leukemia (AML).
Leave A Comment